+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Glioma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Glioma - Epidemiology Forecast - 2032

  • Report
  • April 2023
  • 197 Pages
  • Global
From
POTELIGEO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

POTELIGEO Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
ADCETRIS Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ADCETRIS Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
LYNPARZA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYNPARZA Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
ROZLYTREK Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ROZLYTREK Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
VITRAKVI Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VITRAKVI Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 60 Pages
  • Global
From
From
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 162 Pages
  • Global
From
From
Gazyva Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Gazyva Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Low-Grade Glioma - Epidemiology Forecast-2032 - Product Thumbnail Image

Low-Grade Glioma - Epidemiology Forecast-2032

  • Report
  • August 2022
  • 80 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more